Comments on: Amryt Pharma shares spike 51% with treatment passing rare skin disease trial https://ukinvestormagazine.co.uk/amryt-pharma-shares-spike-by-51-with-treatment-passing-rare-skin-disease-trial/ UK Investor Magazine provides breaking financial news and investment ideas Fri, 13 Nov 2020 13:35:02 +0000 hourly 1 https://wordpress.org/?v=6.9.4 By: Synairgen shares bounce 30% as SNG001 shown to accelerate COVID-19 recovery - UK Investor Magazine https://ukinvestormagazine.co.uk/amryt-pharma-shares-spike-by-51-with-treatment-passing-rare-skin-disease-trial/#comment-16302 Fri, 13 Nov 2020 13:35:02 +0000 https://ukinvestormagazine.co.uk/?p=30876#comment-16302 […] on Friday, as the company reports that its SG016 trial demonstrated the efficacy of its SNG001 treatment in treating patients with […]

]]> By: RedX Pharma shares rally 29% on research collaboration with Jazz Pharmaceuticals - UK Investor Magazine https://ukinvestormagazine.co.uk/amryt-pharma-shares-spike-by-51-with-treatment-passing-rare-skin-disease-trial/#comment-15887 Wed, 09 Sep 2020 12:16:19 +0000 https://ukinvestormagazine.co.uk/?p=30876#comment-15887 […] and fibrosis focused drug development company RedX Pharma plc (AIM:REDX) saw its shares rally by almost 29% to around 90.00p a share […]

]]>